|
Neurochem Inc. is a dynamic, highly energized biopharmaceutical company with an exciting vision and
future, located in the Parc scientifique et de haute technologie de Laval, in Quebec, Canada.
Neurochem's strategic plan focuses on the research, development and commercialization of products to provide innovation health solutions to patients suffering from serious diseases.
With promising drug candidates currently in clinical trials
and with expanding drug development programs, Neurochem is
a company coming of age.
The Company was founded in 1993 by the technology transfer office of Queen's University, Parteq Research and Development
Innovations, in Kingston, Ontario, Canada, to develop and commercialize small organic
molecules. These molecules, discovered by lead researchers at the university, form the basis of
Neurochem's unique technology. Today, Neurochem is proud to count on the dedication of a team of
close to 200 researchers, management and staff.
To advance the development of its breakthrough technologies through clinical trial and
commercialization phases, Neurochem has entered and continues to negotiate a variety of
international R&D agreements, partnerships, collaborations and contracts with renowned
scientists, researchers, academic institutions, pharmaceutical companies and contract research
organizations, while maintaining the full ownership of its therapeutic rights.
|
|
